MPG.eBooks - Description: Sodium-glucose cotransporter 2 inhibitors for the treatment of diabetic nephropathy

Read Now

The purpose of this report is to review the clinical effectiveness of SGLT2 inhibitors for treatment of diabetic nephropathy (T2D with CKD)

Bibliographic Details
Main Authors:	Banerjee, Srabani, Grobelna, Aleksandra (Author)
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa Canadian Agency for Drugs and Technologies in Health September 20, 2019, 2019
Edition:	Version: 1.0
Series:	CADTH rapid response report: summary with critical appraisal
Subjects:	Canada Sodium-glucose Transporter 2 Inhibitors / Therapeutic Use Randomized Controlled Trials As Topic Diabetic Nephropathies / Drug Therapy Treatment Outcome
Online Access:	http://www.ncbi.nlm.nih.gov/books/NBK549580
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The purpose of this report is to review the clinical effectiveness of SGLT2 inhibitors for treatment of diabetic nephropathy (T2D with CKD)
Physical Description:	1 PDF file (38 pages) illustration